@Sorepocket,
Not effective if you are really sick? So people with Covid on ventilators aren't really sick? The results are right there in your face. Massive reduction in mortality. Remestemcel-L reduced mortality by 75% and increased days alive off mechanical ventilation in patients under age 65 when combined with dexamethasone, in comparison with controls on dexamethasone. They weren't giving it to people with a good chance of surviving, 45 percent were dying with dexamethasone alone, and only 14 percent died when Remestemcel-L was added. So, if you give Remestemcel-L to 100 patients, and it prevents 31 deaths (45-14), do you really think the cost of treating 100 isn't worth those 31 lives saved?
Ann: COVID ARDS Trial Topline 60-Day Results, page-308
-
- There are more pages in this discussion • 1,321 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |